Close Menu

Johne's disease

The team will employ reverse vaccinology coupled with high-throughput genomics approaches, such as RNA-seq, to deliver the new vaccines within four years.

Life Technologies said this week that it has signed an agreement with Copan Flock to provide an integrated, end-to-end system for DNA forensics.

NEW YORK (GenomeWeb News) – GeneThera announced today that its wholly owned subsidiary Applied Genetics has signed a deal with the Universidad National Autonoma de Mexico to validate GeneThera's platform for Johne's disease.

GeneThera is currently negotiating formal licensing agreements with the Universita di Roma "Tor Vegata" and Universita Cattolica del Sacro Cuore, which have jointly developed a potential liposome-based therapeutic for Johne's disease, an uncurable bacterial disease affecting the intestinal tract of livestock.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

Time magazine looks into how liquid biopsies are changing cancer care.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.